NPI 1144473208: Open Payments
NPI 1144473208. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 9 payments from 5 companies in 2025. Trend: 2023 $20,530 · 2024 $15,688 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Braeburn Inc. | 2 | $28 |
| Medtronic, Inc. | 1 | $16 |
| Corium, LLC | 1 | $16 |
Products named: CAPLYTA, TZIELD, BRIXADI, INTELLIS ADAPTIVESTIM, Azstarys.
